Artemisinin

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Key facts

Artemisinin is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including CYP1A2. Recorded indications include Falciparum malaria.

• Molecular targets: CYP1A2 (1 listed in DrugCentral).
• Indications: Falciparum malaria.
• ATC code: P01BE01 (Artemisinin and derivatives, plain).
• Molecular formula: C15H22O5; molecular weight 282.34 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Falciparum malaria

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Cytochrome P450 1A2	CYP1A2	unknown	IC50 5.70

ATC classification

ATC code	Therapeutic hierarchy
P01BE01	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, plain
P01BF07	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations
P01BF08	ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations

Chemical structure

• Molecular formula: C₁₅H₂₂O₅
• Molecular weight: 282.34 g/mol
• CAS number: 63968-64-9
• InChIKey: BLUAFEHZUWYNDE-NNWCWBAJSA-N
• PubChem CID: 68827

C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Artemisinin used for?

DrugCentral lists the following indications for Artemisinin: Falciparum malaria.

How does Artemisinin work?

Its molecular targets in DrugCentral include CYP1A2.

What is the chemical formula of Artemisinin?

Artemisinin has the molecular formula C15H22O5 and a molecular weight of 282.34 g/mol.

Sources

• DrugCentral drug card 3871 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL269671 — compound record and bioactivity
• PubChem CID 68827 — chemical identifiers
• DrugBank DB13132 — drug record
• FDA UNII 9RMU91N5K2 — substance identity
• UniProt P05177 (CYP1A2) — target protein

How this page is built: methodology · editorial policy & corrections.